Loading company
Latest annual · FY2025
Millions- Operating income
- (7)
- Net income
- (7)
- Free cash flow
- (7)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
Genenta Science S.p.A. (GNTA) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -€6.6 million | -€9.8 million | 20-F 2026-04-01 · proof | |
| Net income | -€6.5 million | -€8.9 million | 20-F 2026-04-01 · proof | |
| Cash from operating activities | -€6.9 million | -€6.2 million | 20-F 2026-04-01 · proof | |
| Free cash flow | -€6.9 million | -€6.2 million | 20-F 2026-04-01 · proof | |
| Total assets | €31.9 million | €14.8 million | +115.1% | 20-F 2026-04-01 · proof |
| Total liabilities | €10 million | €2.3 million | +331.6% | 20-F 2026-04-01 · proof |
| Cash and cash equivalents | €5.5 million | €4.6 million | +20.6% | 20-F 2026-04-01 · proof |
- What was Genenta Science S.p.A. (GNTA)'s operating income in fiscal 2025?
- Genenta Science S.p.A. (GNTA) reported operating income of -€6.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -€9.8 million the year before. Source: the 20-F filed with the SEC on Apr 1, 2026. SEC
- What was Genenta Science S.p.A. (GNTA)'s net income in fiscal 2025?
- Genenta Science S.p.A. (GNTA) reported net income of -€6.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -€8.9 million the year before. Source: the 20-F filed with the SEC on Apr 1, 2026. SEC
- What was Genenta Science S.p.A. (GNTA)'s cash from operating activities in fiscal 2025?
- Genenta Science S.p.A. (GNTA) reported cash from operating activities of -€6.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -€6.2 million the year before. Source: the 20-F filed with the SEC on Apr 1, 2026. SEC
- What was Genenta Science S.p.A. (GNTA)'s free cash flow in fiscal 2025?
- Genenta Science S.p.A. (GNTA) reported free cash flow of -€6.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -€6.2 million the year before. Source: the 20-F filed with the SEC on Apr 1, 2026. SEC
- What are Genenta Science S.p.A. (GNTA)'s total assets?
- As of Dec 31, 2025, Genenta Science S.p.A. (GNTA) reported total assets of €31.9 million, against €14.8 million a year earlier (+115.1%). Source: the 20-F filed with the SEC on Apr 1, 2026. SEC
- What are Genenta Science S.p.A. (GNTA)'s total liabilities?
- As of Dec 31, 2025, Genenta Science S.p.A. (GNTA) reported total liabilities of €10 million, against €2.3 million a year earlier (+331.6%). Source: the 20-F filed with the SEC on Apr 1, 2026. SEC
- What are Genenta Science S.p.A. (GNTA)'s cash and cash equivalents?
- As of Dec 31, 2025, Genenta Science S.p.A. (GNTA) reported cash and cash equivalents of €5.5 million, against €4.6 million a year earlier (+20.6%). Source: the 20-F filed with the SEC on Apr 1, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:GNTA&period_type=annual&limit=5"Information only, not investment advice.